Free Papers: Potpourri I - Abstracts 41-48
41 - Hpb Nsqip: Potential For Quality Improvement, Registries, And Clinical Trials
Henry A Pitt, MD, Molly Kilbane, RN, BSN, Nicholas J. Zyromski, MD, Thomas A. Aloia, MD, J. Michael Henderson, MD, Sean J. Mulvihill, MD, Indiana University, Indianapolis, IN; The Methodist Hospital, Houston, TX; Cleveland Clinic, Cleveland, OH; University of Utah, Salt Lake City, UT.
42 - Clinical Factors Predictive of Malignant and Premalignant Cystic Neoplasms of the Pancreas
Natalie B Jones, MD, E. Christopher Ellison, MD, W. Scott Melvin, MD, Peter Muscarella, MD, Mark Bloomston, MD, The Ohio State University, Columbus, OH.
43 - Escalating Computed Tomography Angiogram (CTA) Grade Predicts Unresectability and Positive Margins For Pancreaticobiliary
Neoplasms
Tara S Kent, MD, Alphonso Brown, MD, Mark P Callery, MD, Vassilios D Raptopoulos, MD, Charles M Vollmer, MD, Beth Israel Deaconess Medical Center, Boston, MA.
44 - Neoadjuvant therapy may lead to successful surgical resection and improved survival in patients with borderline resectable pancreas
cancer
Rebecca J Mcclaine, MD, Andrew M Lowy, MD, Jeffrey J Sussman, MD, Faheem Ahmed, MD, Nathan Schmulewitz, MD, David Grisell, MD, Michael J Edwards, MD, Syed A Ahmad, MD, University of Cincinnati, Cincinnati, OH.
45 - Multimodal therapy for treatment of hepatocellular carcinoma: A ten-year survival analysis.
Andrew Schumacher, MD, James Powell, MD, Andrzej Buczkowski, MD, Charles Scudamore, MD, Stephen Ho, MD, Stephen Chung, MD, PhD,University of British Columbia, Vancouver, BC, Canada; Royal Infirmary of Edinburgh, Edinbugh, United Kingdom.
46 - Results Of Total Pancreatectomy: A Single Center Experience
John Stauffer, MD, C. Dan Smith, MD, J. Kirk Martin, MD, Justin Nguyen, MD, Mayo Clinic, Jacksonville, FL.
47 - Predicting Poor Outcome Following Hepatectomy: Analysis of 2,313 Hepatectomies in the NSQIP Database
Thomas A Aloia, MD, Bridget N Fahy, Craig P Fischer, MD, Stephen L Jones, MD, Andrea Duchini, MD, Joseph Galati, MD, A O Gaber, MD, Barbara L Bass, MD, R Mark Ghobrial, MD, PhD, The Methodist Hospital, Houston, TX.
48 - Validation Of The Meld Based Objective Scoring System (Moss): Unresectable Hepatocellular Carcinoma In Patients With Cirrhosis
Swee H Teh, Chet Hammill, MD, Linda Wong, MD, Brett Sheppard, MD, Jonathan Schwartz, MD, Kaufman John, MD, Ken Kolbeck, MD, Steve Cha,PhD, Susan Orloff, MD, Sacred Heart Medical Center, Eugene, OR; University of Hawaii, Honolulu, HI; Oregon Health Sciences University, Portland,OR; Mayo Clinic, Rochester, MN.
48a - Interpreting three-dimensional structures from two-dimensional images: a web-based interactive 3D model of the liver to enhance
surgical residents; spatial understanding of structural inter-relationships
Jodi Crossingham, B.Sc., Jodie Jenkinson, Nick Woolridge, Steven Gallinger, MD, Carol-anne Moulton, MD, Toronto General Hospital, Toronto, ON,Canada; University of Toronto, Toronto, ON, Canada.